Hyperinsulinemia has been proposed to promote liver steatosis [19] and hyperinsulinemic patients with NASH treated with insulin-sensitizing agents show improvements of liver steatosis [24]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.